Delivery Order SPE2DB22D2206-SPE2DB24FHY31

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award has been granted to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is for the delivery of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription medication, to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract, valued at $1,741.68, is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5ml to the Defense Logistics Agency (DLA). The $2,031.96 award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract, valued at $2,174.61, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 20, 2024. The contract is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $3,773.64 and a completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 3 mg/0.5 ml pens. The contract, valued at $2,902.80, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 14, 2024. The contract is a delivery order with a firm fixed price pricing type. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (0.75 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA). The $1,741.68 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and medical supply provider to the U.S. government. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pen 0.5 ml. The contract, valued at $8,176.61, is a Delivery Order awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 22, 2023. The contract is not designated with a set-aside and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen in 0.5 ml doses. The contract has a ceiling value of $4,335.49 and a completion date of May 30, 2024. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $54,818.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The award, valued at $1,741.68, is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential total value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHY31
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp. is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen in 0.5 ml quantities. The award, valued at $1,741.68, was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen's Corporate Office division.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/26/24, 9:38 AM